1259 Objectives: Non-invasive diagnosis of cancer is a enormous challenge in clinics due to
the rising number of patients. A biopsy or surgery is often required to justify the malignancy …

1061 Objectives Non-invasively differentiating tumor from inflammation is a long-standing
challenge for cancer diagnosis. In clinics, a biopsy or surgery is often required to justify the …

Boronophenylalanine (BPA) is the dominant boron delivery agent for boron neutron capture
therapy (BNCT), and [18F] FBPA has been developed to assist the treatment planning for …

222 Objectives The transportation of amino acids is known to be upregulated in many types
of tumor cells. Therefore, development of traceable amino acids for cancer imaging is of …

Breast cancer is the most common malignancy among women in the world. Its 5-year
survival rate ranges from 23.4% in patients with stage IV to 98% in stage I disease …

136 Objectives Radiolabeled tyrosine analogs target up-regulated amino acid transport
system and have shown to be superior to FDG in differential diagnosis in cancers. This study …

1216 Objectives: This work was designed to perform the very-first study of investigating the
safety, biodistribution, and radiation dosimetry of large amino acid transporter (LAT) …

Purpose In this work, the safety, biodistribution, and radiation dosimetry of large neutral
amino acid transporter type-1 (LAT-1) targeting PET tracer 18 F-trifluorobborate-derived …

Purpose Boramino acids are a class of amino acid biomimics that replace the carboxylate
group with trifluoroborate and can achieve the 18 F-labeled positron emission tomography …

Purpose: Positron emission tomography (PET) and single photon emission computed
tomography (SPECT) tracers have been applied to pharmacokinetic, pharmacodynamic …